GENE ONLINE|News &
Opinion
Blog

2025-04-02|

Generic Drug Makers Prioritize Skilled Staff and Robust Testing for High Quality Standards

by Mark Chiang
Share To

Generic drug manufacturers must prioritize a commitment to excellence in people, processes, and technology to achieve high-quality standards. Sources emphasize the importance of investing in skilled personnel and robust quality control measures, including regular product testing and inspection. They also highlight the need to stay informed about evolving regulatory requirements and proactively address potential issues while fostering transparency and accountability within the organization. To produce high-quality generic drugs, manufacturers must meticulously execute every step of the process, from sourcing active pharmaceutical ingredients (APIs) to implementing quality control measures. This requires a comprehensive understanding of the regulatory landscape and a willingness to adapt to changing standards, along with a commitment to transparency and accountability to address issues quickly and effectively. Individuals can learn more about these standards and industry trends at https://www.drugpatentwatch.com/blog/how-to-achieve-high-quality-standards-in-generic-drugs/.

Newsflash | Powered by GeneOnline AI
Source: https://www.drugpatentwatch.com/blog/how-to-achieve-high-quality-standards-in-generic-drugs/ Wed, 02 Apr 2025 00:13:04 +0000

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Related Post
LATEST
Abaxx Exchange to Integrate with TMX Trayport’s Joule Platform for Enhanced Trading Access
2026-02-08
Luckin Coffee Opens 30,000th Store with Launch of Origin Flagship Location
2026-02-08
Study Finds Nitazene-Linked Deaths in UK Underreported by 33 Percent
2026-02-08
ICE Launches FTSE South Korea RIC Capped Index Futures on February 9, 2026
2026-02-08
New Model Maps Pedestrian Foot Traffic Across New York City During Peak Travel Periods
2026-02-08
TG Therapeutics Partners with Christina Applegate to Raise Awareness About Multiple Sclerosis
2026-02-08
New Program Resilient Together for Dementia Addresses Mental Health Needs of Patients and Caregivers
2026-02-08
EVENT
2026-02-09
World Health Expo Dubai
Dubai Exhibition Centre, Dubai
2026-02-17
BIO Asia 2026 (Life Science Partnerships)
Hyderabad, India
2026-02-24
Rare Disease Week on Capitol Hill (Policy and Advocacy)
Capitol Hill, Washington, D.C.
2026-03-09
HIMSS26 (Digital Health & Hospital IT)
Las Vegas, Nevada
2026-03-23
BIO Europe Spring (Biotech Partnering)
Lisbon, Portugal
Scroll to Top